• Blog
  • Careers
  • Coalitions
  • Directory
  • Donate
  • Members
  • Toolbox
  • Your TB Story
0 Items
CTCA
  • About
    • Executive Committee
    • Honors
    • Staff
  • Civil Surgeons
  • Events
    • 2020 Conference is now Two 2Hour Zoom Mtgs
    • Archives
    • World TB Day
  • Guidance
    • CDPH-CTCA Joint Guidelines
    • Health Care Personnel TB Screening
    • Additional Resources
    • CDC Guidelines
  • Patients
  • Providers
  • News-Alerts
Select Page

Latent TB Infection Guideline

Table of Contents

DOWNLOAD PDF FILE

Links labeled “CDPH LINK” in red, will take you to the CDPH website where they can be downloaded individually. Please note that these pieces have the same content as the information provided in this guideline.

Introduction

Background

Who to Test:

California Tuberculosis Adult Risk Assessment and User Guide (September 2018) (CDPH LINK)
California Tuberculosis Pediatric Risk Assessment and User Guide (September 2018) (CDPH LINK)

Selecting a Test for Latent TB Infection (LTBI) (June 2019)

Evaluating Patients with a Positive TB Test

Choice of Treatment for Latent TB Infection (LTBI)

12 dose Isoniazid (INH) + Rifapentine Regimen for Latent TB Infection Treatment (September 2018) (CDPH LINK)
Rifampin for Latent TB Infection Treatment (September 2018) (CDPH LINK)
Isoniazid (INH) for Latent TB Infection Treatment (September 2018) (CDPH LINK)

Resources

References


  • Contact Us
  • Facebook
  • Twitter
  • LinkedIn
© 2016-2020 CTCA All Rights Reserved. Web Design and Development by IES, Inc - Server: IES-WEB-V3-1.